Gastroenteritis Clinical Trials Gastroenteritis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
Condition:   Human Papillomavirus Infection Interventions:   Biological: Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli);   Biological: Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine Sponsors:   Beijing Health Guard Biotechnology, Inc;   Jiangsu Province Centers for Disease Control and Prevention;   National Institutes for Food and Drug Control, China;   Nanjing Sangruisi Pharmaceutical Technology Co., Ltd;   School of Public Health of Southeastern University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2023 Category: Research Source Type: clinical trials

A Phase I Trial to Evaluate the Safety and Tolerability Profile of HPV Vaccine
Condition:   Human Papillomavirus Infection Interventions:   Biological: Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli);   Biological: Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine Sponsors:   Beijing Health Guard Biotechnology, Inc;   Jiangsu Province Centers for Disease Control and Prevention;   National Institutes for Food and Drug Control, China;   Nanjing Sangruisi Pharmaceutical Technology Co., Ltd;   School of Public Health of Southeastern University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2023 Category: Research Source Type: clinical trials